Ferrum Lek® (iron (III) hydroxide polymaltosate), 100 mg chewable tablets (Lek d.d., Slovenia)

Phase 3

Phase 3

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Mild and Moderate Iron-deficiency Anaemia

Drug Information

Target Indication

Mild and Moderate Iron-deficiency Anaemia

Clinical Trial

Last updated: 6/28/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

SDZ.SW

Sandoz Group AG

Related Pipeline

Rhinitis, Allergic, Seasonal

Chronic Kidney Disease

Anemia

Chronic Stable Plaque Psoriasis

Neovascular Age-related Macular Degeneration

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts